Treatment of Primary CNS Lymphoma With High-Dose Methotrexate in Immunocompetent Pediatric Patients

被引:15
|
作者
Shah, Amish C. [1 ]
Kelly, David R. [2 ]
Nabors, L. Burt [3 ]
Oakes, W. Jerry [4 ]
Hilliard, Lee M. [5 ]
Reddy, Alyssa T. [3 ,4 ,5 ]
机构
[1] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA
[2] Univ Alabama Birmingham, Dept Pathol, Sch Med, Birmingham, AL 35294 USA
[3] Univ Alabama Birmingham, Dept Neurol, Sch Med, Birmingham, AL 35294 USA
[4] Univ Alabama Birmingham, Sch Med, Dept Surg, Birmingham, AL 35294 USA
[5] Univ Alabama Birmingham, Sch Med, Dept Pediat, Birmingham, AL USA
关键词
anaplastic large cell lymphoma; diffuse large B-cell lymphoma; methotrexate; primary central nervous system lymphoma; CENTRAL-NERVOUS-SYSTEM; LONG-TERM SURVIVAL; THERAPEUTIC MANAGEMENT; EPIDEMIOLOGY;
D O I
10.1002/pbc.22752
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We report two cases of primary CNS lymphoma (PCNSL) treated with high-close methotrexate. Though standard adult treatment of PCNSL incorporates whole-brain radiotherapy, the literature suggests it may be possible to delay or avoid radiotherapy and the associated increased risk of neurologic sequelae in pediatric patients. Studies in adults indicate methotrexate therapy can be effective against PCNSL and has advantages over the current standard of treatment. Both patients have no evidence of disease 9 and 7 years after treatment, suggesting high-close methotrexate may lead to disease control in pediatric patients with PCNSL while avoiding the effects of radiotherapy. Pediatr Blood Cancer. 2010;55:1227-1230. (C) 2010 Wiley-Liss, Inc.
引用
收藏
页码:1227 / 1230
页数:4
相关论文
共 50 条
  • [1] Treatment of Primary CNS Lymphoma With High-Dose Methotrexate in Immunocompetent Patients
    Cohen, Ian Joseph
    PEDIATRIC BLOOD & CANCER, 2011, 56 (07) : 1151 - 1151
  • [2] High-dose methotrexate for elderly patients with primary CNS lymphoma
    Zhu, Jay-Jiguang
    Gerstner, Elizabeth R.
    Engler, David A.
    Mrugala, Maciej M.
    Nugent, Whitney
    Nierenberg, Kristin
    Hochberg, Fred H.
    Betensky, Rebecca A.
    Batchelor, Tracy T.
    NEURO-ONCOLOGY, 2009, 11 (02) : 211 - 215
  • [3] Treatment of primary CNS lymphoma with high-dose methotrexate in the immunocompromised population
    New, Pamela
    NEURO-ONCOLOGY, 2006, 8 (04) : 447 - 447
  • [4] High-dose methotrexate for primary CNS lymphoma in the elderly
    Ng, S
    Rosenthal, MA
    Ashley, D
    Cher, L
    NEURO-ONCOLOGY, 2000, 2 (01) : 40 - 44
  • [5] Clinical utility and pharmacology of high-dose methotrexate in the treatment of primary CNS lymphoma
    Green, Myke R.
    Chowdhary, Sajeel
    Lombardi, Kristina M.
    Chalmers, Lisa M.
    Chamberlain, Marc
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2006, 6 (05) : 635 - 652
  • [6] High-Dose Methotrexate, Rituximab, and Temozolomide (MRT) for Patients with Primary CNS Lymphoma (PCNSL).
    Gerstner, Elizabeth R.
    Hochberg, Fred H.
    Plotkin, Scott R.
    Eichler, April F.
    Batchelor, Tracy T.
    BLOOD, 2009, 114 (22) : 667 - 667
  • [7] HIGH-DOSE METHOTREXATE BASED IMMUNOCHEMOTHERAPY WITH MAINTENANCE CHEMOTHERAPY WITH HIGH-DOSE METHOTREXATE AND DEFERRED RADIOTHERAPY FOR ELDERLY PRIMARY CNS LYMPHOMA PATIENTS
    Mishima, K.
    Miyake, Y.
    Kobayashi, Y.
    Suzuki, T.
    Adachi, J.
    Fujimaki, T.
    Nishikawa, R.
    NEURO-ONCOLOGY, 2017, 19 : 108 - 109
  • [8] High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial
    Ferreri, Andres J. M.
    Reni, Michele
    Foppoli, Marco
    Martelli, Maurizio
    Pangalis, Gerasimus A.
    Frezzato, Maurizio
    Cabras, Maria Giuseppina
    Fabbri, Alberto
    Corazzelli, Gaetano
    Ilariucci, Fiorella
    Rossi, Giuseppe
    Soffietti, Riccardo
    Stelitano, Caterina
    Vallisa, Daniele
    Zaja, Francesco
    Zoppegno, Lucia
    Aondio, Gian Marco
    Avvisati, Giuseppe
    Balzarotti, Monica
    Brandes, Alba A.
    Fajardo, Jose
    Gomez, Henry
    Guarini, Attilio
    Pinotti, Graziella
    Rigacci, Luigi
    Uhlmann, Catrina
    Picozzi, Piero
    Vezzulli, Paolo
    Ponzoni, Maurilio
    Zucca, Emanuele
    Caligaris-Cappio, Federico
    Cavalli, Franco
    LANCET, 2009, 374 (9700): : 1512 - 1520
  • [9] High-Dose Methotrexate In The Treatment Of Primary Testicular Lymphoma
    Reinius, Marika
    Ahmad, Saif S.
    Crawley, Charles
    Williams, Michael V.
    Wimperis, Jennie
    Follows, George A.
    BLOOD, 2013, 122 (21)
  • [10] High-dose methotrexate with or without rituximab in newly diagnosed primary CNS lymphoma
    Holdhoff, Matthias
    Ambady, Prakash
    Abdelaziz, Ahmed
    Sarai, Guneet
    Bonekamp, David
    Blakeley, Jaishri
    Grossman, Stuart A.
    Ye, Xiaobu
    NEUROLOGY, 2014, 83 (03) : 235 - 239